Spruce Biosciences SPRB
NASDAQ SPRB
$48.40 +1.13 (+2.37%)
As of: Sep 30, 2026 · 9:57 AM EDT

Spruce Biosciences (SPRB) EV to CFO (2025 - 2026)

Updated

Spruce Biosciences' (SPRB) EV to CFO came in at 2.74 for Q2 2026.

Analysis

Spruce Biosciences (SPRB) EV to CFO (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to CFO at Spruce Biosciences was -3.20.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Spruce Biosciences 130.79 Mn 130.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.74
Sep 30, 2025 -0.90
API Access

Spruce Biosciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SPRB&period=max&api_key=YOUR_API_KEY